Edition:
United States

Sinclair Pharma PLC (SPH.L)

SPH.L on London Stock Exchange

22.65GBp
19 Jan 2018
Change (% chg)

-0.20 (-0.88%)
Prev Close
22.85
Open
23.10
Day's High
23.10
Day's Low
22.40
Volume
429,647
Avg. Vol
340,103
52-wk High
36.12
52-wk Low
21.00

Chart for

About

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and... (more)

Overall

Beta: 0.03
Market Cap(Mil.): £114.10
Shares Outstanding(Mil.): 503.77
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 33.09 17.86
EPS (TTM): -- -- --
ROI: -- 15.01 33.11
ROE: -- 16.57 17.05

BRIEF-Sinclair Pharma Says Gets Regulatory Approval Of Ellanse By Anvisa In Brazil​

* ‍ANNOUNCE THAT IT HAS RECEIVED REGULATORY APPROVAL OF ELLANSÉ® BY ANVISA IN BRAZIL​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

Jan 16 2018

Sinclair Pharma H1 sales up 16 pct, sees momentum continuing

Sept 19 Sinclair Pharma reported a 16 percent rise in first-half revenue on strong demand in Brazil for its aesthetic dermatology products, adding that it expects much higher sales in the second half of the year.

Sep 19 2017

BRIEF-Sinclair Pharma expects H2 sales to be considerably higher than H1​

* EXPECT TREND OF SALES AND PROFITABILITY MOMENTUM TO CONTINUE FOR MEDIUM TERM​

Sep 19 2017

Earnings vs. Estimates